Clinical Trial Update: A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) [Phase 1]

View source ↗

Summary

Kura Oncology is conducting a Phase 1 study of Ziftomenib in combination with Imatinib for advanced gastrointestinal stromal tumors, and the trial is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Imatinib (imatinib)
• Ziftomenib (ziftomenib)

Snippet

Sponsor: Kura Oncology, Inc. | Conditions: Gastrointestinal Stromal Tumor (GIST), Gastrointestinal Stromal Cancer | Phase 1 | Status: RECRUITING